Abstract
Mikołaj Biegański, Joanna Matysiak, Monika Szeliga
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024
Drug repurposing for cancer therapy
10.1038/s41392-024-01808-1 · 2024
Coumarin derivatives as anticancer agents: mechanistic landscape with an emphasis on breast cancer
10.3390/molecules30214167 · 2025
Synthesis, in vitro antitumor activity and molecular mechanism of novel furan derivatives and their precursors
10.2174/1871520620666200424130204 · 2020
Harnessing chromone as a versatile scaffold for emerging biological applications: recent advances and medicinal insights
10.1002/tcr.202500073 · 2025
Anticancer therapeutic potential of benzofuran scaffolds
10.1039/d3ra01383a · 2023
Unveiling the anti-cancer properties of apigenin via targeting different molecular signatures: a review
10.1007/s11033-026-11976-8 · 2026
Oxazole derivatives as promising kinase inhibitors: a new era in cancer drug discovery
10.1016/j.bioorg.2026.109979 · 2026
N-heterocycles: recent advances in biological applications
10.2174/1570193x19666211231101747 · 2023
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
A review on the medicinal and industrial applications of n-containing heterocycles
10.2174/18741045-v16-e2209010 · 2022
Imidazole-based chemosensors: a promising approach for trace copper(II) monitoring
10.1016/j.ica.2025.122983 · 2026
Facile one-pot synthesis of imidazole (MID): a highly sensitive turn-off fluorescence probe for mercury (II) ion detection
10.55559/jjbrpac.v3i1.623 · 2026
An update on the nitrogen heterocycle compositions and properties of U.S. FDA-approved pharmaceuticals (2013–2023)
10.1021/acs.jmedchem.4c01122 · 2024
Recent developments in the antimicrobial potential of some nitrogenous heterocycles and their SAR studies: a review
10.2174/0109298673301266240506083014 · 2025
Recent research frontiers of heterocycles as antifungal agents: insights from the past five years
10.1016/j.ejmech.2025.117801 · 2025
Recent development of heterocyclic compounds with indazole moiety as potential antiparasitic agents
10.2174/1568026622666220415224139 · 2022
Allosteric GABAA receptor modulators—a review on the most recent heterocyclic chemotypes and their synthetic accessibility
10.3390/molecules25040999 · 2020
The pyrazole scaffold in anticancer drug discovery: a review of synthetic approaches, structure–activity relationships, and target-based mechanism of action
10.3390/ijms27083403 · 2026
Actions of novel angiotensin receptor blocking drugs, bisartans, relevant for COVID-19 therapy: biased agonism at angiotensin receptors and the beneficial effects of neprilysin in the renin angiotensin system
10.3390/molecules27154854 · 2022
An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors
10.1007/s11030-024-11016-2 · 2025
Triptans in Migraine
10.2165/00003495-200060060-00003 · 2000
Quinolines and structurally related heterocycles as antimalarials
10.1016/j.ejmech.2010.04.011 · 2010
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
10.1016/j.pharmthera.2019.107447 · 2020
Combined cytotoxic chemotherapy and immunotherapy of cancer: modern times
10.1093/narcan/zcaa002 · 2020
The fluoropyrimidine polymer CF10 synergizes with 5-ethynyl-2′-deoxyuridine by promoting telomere attrition and mitotic catastrophe
10.1093/narmme/ugag005 · 2026
A review on medicinal approaches of novel imatinib derivatives
10.2174/0115680266332163241127114029 · 2025
Kinase drug discovery 20 years after imatinib: progress and future directions
10.1038/s41573-021-00195-4 · 2021
Application and pharmacological mechanism of methotrexate in rheumatoid arthritis
10.1016/j.biopha.2022.113074 · 2022
The pharmacology and clinical use of methotrexate
10.1056/nejm198311033091805 · 1983
Temozolomide: an updated overview of resistance mechanisms, nanotechnology advances and clinical applications
2021
Exosomes in the chemoresistance of glioma: key point in chemoresistance
10.1111/jcmm.70401 · 2025
Exploring tetrazole chemistry: synthetic techniques, structure–activity relationship, and pharmacological insights in antimicrobial and anticancer therapy
10.3389/fchem.2025.1700143 · 2025
A new generation of N-heterocyclic carbene (NHC) gold–selenolato complexes as potent anticancer agents: distinct synthetic routes and evaluation in 2D and 3D cancer models
10.1039/d5sc04490a · 2025
Synthesis and biological activity of structurally diverse phthalazine derivatives: a systematic review
10.1016/j.bmc.2019.07.050 · 2019
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation
10.1039/d4ra03459g · 2024
Phthalazine scaffolds in medicinal chemistry: a review of their synthesis, versatility, and pharmacological significance
10.1007/s11030-026-11489-3 · 2026
Synthetic and medicinal chemistry of phthalazines: recent developments, opportunities and challenges
10.1016/j.bioorg.2020.104425 · 2020
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
10.1073/pnas.0806092105 · 2008
Inhibition of poly(ADP-Ribose) polymerase in tumors from BRCA mutation carriers
10.1056/nejmoa0900212 · 2009
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
10.1016/s1470-2045(14)70228-1 · 2014
Design and synthesis of novel phthalazine and benzofuran scaffolds using CoFe2O4@CNSCu nanocatalyst: evaluation of PARP-1 inhibitory activity
10.1016/j.jorganchem.2025.123997 · doi-reference
An efficient one-pot synthesis of pyridazinones and phthalazinones using HY-zeolite
10.1002/jhet.649 · doi-reference
Green one-pot synthesis of thiazole scaffolds catalyzed by reusable NiFe 2 O 4 nanoparticles: In silico binding affinity and in vitro anticancer activity studies
10.1021/acsomega.4c05587 · doi-reference
Novel green synthesis of polyfunctionally substituted phthalazines promoted by visible light, DFT studies and molecular docking with antimicrobial and antibiofilm potency
10.1038/s41598-026-47154-w · doi-reference
Controlled microwave-assisted reactions: a facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line
10.1016/j.bioorg.2022.105740 · doi-reference
A convenient metal-free one-pot synthesis of some phthalazine derivatives mediated by 3-picolinic acid
10.1007/s11164-025-05682-6 · doi-reference
Reaction of 1-nitroso-2-naphthols with α-functionalized ketones and related compounds: the unexpected formation of decarbonylated 2-substituted naphtho[1,2-d][1,3]oxazoles
10.1021/jo3022956 · doi-reference
Palladium-catalyzed synthesis of 4-aminophthalazin-1(2H)-ones by isocyanide insertion
10.1021/ol202784d · doi-reference
Multicomponent synthesis of 4-aminophthalazin-1(2H)-ones by palladium-catalyzed isocyanide insertion
10.1021/jo401131p · doi-reference
Microwave assisted palladium-catalyzed synthesis of phthalazinones and pyridopyridazinones
10.1016/j.tetlet.2013.05.006 · doi-reference
Synthesis of tetrahydrophthalazine and phthalamide (phthalimide) derivatives via palladium-catalysed carbonylation of iodoarenes
10.1016/j.tet.2011.09.095 · doi-reference
Palladium-catalyzed synthesis of phthalazinones: efficient carbonylative coupling of 2-bromobenzaldehydes and hydrazines
10.1002/chem.201200267 · doi-reference
Palladium-catalyzed phthalazinone synthesis using paraformaldehyde as carbon source
10.1021/ol502498y · doi-reference
Palladium-catalyzed acylation reactions: a one-pot diversified synthesis of phthalazines, phthalazinones and benzoxazinones
10.1002/ejoc.201800159 · doi-reference
Multicomponent reactions with Meldrum’s acid and isocyanides as a valuable synthetic approach: an update
10.1007/s11030-026-11469-7 · doi-reference
Highlighting multicomponent reactions as an efficient and facile alternative route in the chemical synthesis of organic-based molecules: a tremendous growth in the past 5 years
10.3389/fchem.2024.1469677 · doi-reference
Visible light amination/smiles cascade: access to phthalazine derivatives
10.1039/c6sc01095d · doi-reference
Synthesis of the possible carcinogenic dihydrodiol and diol epoxide of phthalazine
10.1016/j.tet.2004.11.071 · doi-reference
The mechanism of the triple aryne–tetrazine reaction cascade: theory and experiment
10.1039/c8sc01796d · doi-reference
Triple aryne-tetrazine reaction enabling rapid access to a new class of polyaromatic heterocycles
10.1039/c5sc01726b · doi-reference
Phthalazine derivatives from aromatic aldazines
10.1016/0040-4039(81)80093-7 · doi-reference
A convenient access to benzo-substituted phthalazines as potential precursors to DNA intercalators
10.1016/s0040-4039(01)01302-8 · doi-reference
Iptycene-derived pyridazines and phthalazines
10.1021/jo702000d · doi-reference
Phthalazines and phthalazine hybrids as antimicrobial agents: synthesis and biological evaluation
10.1177/1747519819883840 · doi-reference
Benzo[4,5]imidazo[2,1-a]phthalazines: I. substituted o-nitrophenylhydrazines in the synthesis of phthalazin-1(2H)-ones
10.1134/s1070428008050175 · doi-reference
Synthesis of benzo[4,5]imidazo[2,1- a] phthalazines
10.1016/j.tetlet.2003.12.070 · doi-reference
Synthesis of 4-substituted chlorophthalazines, dihydrobenzoazepinediones, 2-pyrazolylbenzoic acid, and 2-pyrazolylbenzohydrazide via 3-substituted 3-hydroxyisoindolin-1-ones
10.1021/jo3000628 · doi-reference
New convenient one-step synthesis of 4-arylphthalaz-1 -ones
10.1016/s0040-4020(01)91312-2 · doi-reference
Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives
10.1016/j.ejmech.2010.05.016 · doi-reference
Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
10.1080/14756366.2019.1642883 · doi-reference
Rational design, synthesis, in vitro, and in-silico studies of pyrazole-phthalazine hybrids as new α-glucosidase inhibitors
10.1038/s41598-025-87258-3 · doi-reference
Phthalazine PDE4 inhibitors. Part 2: the synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives
10.1016/s0960-894x(00)00587-4 · doi-reference
An overview of different synthetic routes for the synthesis of phthalazine derivatives
10.9734/jpri/2019/v27i630189 · doi-reference
Anti-HIV activity of stilbene-related heterocyclic compounds
10.1016/j.bmcl.2006.04.087 · doi-reference
Recent advances in the synthesis of phthalazin-1(2H)-one core as a relevant pharmacophore in medicinal chemistry
10.1016/j.ejmech.2018.10.047 · doi-reference
One-pot synthesis of phthalazines and pyridazino-aromatics: a novel strategy for substituted naphthalenes
10.1021/ol301167q · doi-reference
Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors
10.1016/j.bioorg.2019.103004 · doi-reference
N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors
10.1002/jmr.2991 · doi-reference
Prodromal dysfunction of α5GABA-A receptor modulated hippocampal ripples occurs prior to neurodegeneration in the TgF344-AD rat model of Alzheimer’s disease
10.1016/j.heliyon.2021.e07895 · doi-reference
The plasma–occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, α5IA, is similar in rats and primates
10.1111/j.1476-5381.2009.00216.x · doi-reference